FDA 510(k)

DRI 苯二氮卓类药物检测

K号: K173963 · 2018-02-21

决定日期2018-02-21

产品代码JXM

咨询委员会TX 请注意，由于您没有提供具体的医疗设备监管文本，我无法进行翻译。请提供具体的文本内容，以便我能够按照您的要求进行翻译。

决定实质等同

器械摘要

DRI Benzodiazepine Assay is the device name listed in this FDA 510(k) record. The listed applicant is Microgenics Corporation. It received FDA 510(k) clearance on 2018-02-21 under 510(k) number K173963. The device is classified under product code JXM. It was reviewed by the TX advisory panel. FDA Decision: Substantially Equivalent.

常见问题

What is the DRI Benzodiazepine Assay?

DRI Benzodiazepine Assay is a medical device that received FDA 510(k) clearance on 2018-02-21. The listed applicant is Microgenics Corporation. The 510(k) number is K173963.

When did DRI Benzodiazepine Assay receive FDA 510(k) clearance?

DRI Benzodiazepine Assay received FDA 510(k) clearance on 2018-02-21, under 510(k) number K173963.

Who is the listed applicant for DRI Benzodiazepine Assay?

The FDA 510(k) record lists Microgenics Corporation as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for DRI Benzodiazepine Assay?

The FDA product code for DRI Benzodiazepine Assay is JXM.

列明Microgenics Corporation为申报人的其他记录

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系；请查阅链接的官方来源。

K243498Alinity c 苯二氮卓类药物试剂套件 K240670DRI 摇滚药检测 K231020Alinity c 三环类抗抑郁药试剂套件 K231007CEDIA 海洛因代谢物（6-AM）检测 K213875DRI TM 三环类血清毒物检测 K211973DRI 可卡因代谢物检测

查看所有 13 个设备 →

相关器械（代码：JXM）

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系；请查阅链接的官方来源。

K243498Alinity c 苯二氮卓类药物试剂套件Microgenics Corporation K221765ONLINE DAT 苯二氮卓类药物 IIRoche Diagnostics K190968CEDIA 苯二氮卓类药物检测Microgenics Corporation K163590Psychemedics微孔板酶联免疫吸附测定法，用于检测头发中的苯二氮卓类药物Psychemedics Corporation K163704Healgen 多药物尿液测试杯；Healgen 多药物尿液测试条Healgen Scientific,, LLC K153597Healgen 多药物尿液测试杯，Healgen 多药物尿液测试条Healgen Scientific,, LLC

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息，请务必参考官方记录。